Treatment for idiopathic toe walking: a systematic review of the literature.
DOI:
https://doi.org/10.2340/16501977-1881Keywords:
idiopathic toe walking, treatment, review, ITW.Abstract
OBJECTIVE: To assess the effectiveness of currently available treatment options for idiopathic toe walking on the 3 main levels of the World Health Organization International Classification of Functioning, Disability, and Health for Children and Youth (ICF-CY). DESIGN: A systematic search from 1966 to December 2013 in MEDLINE, Current Contents, CINAHL and the Cochrane Library of full-length articles addressing clinical efficacy of treatment in children aged 2-18 years. METHODS: Studies were evaluated using both the Oxford Centre for Evidence-Based Medicine (OCEBM) levels of evidence and the Methodological Index for Non-Randomised Studies (MINORS). Outcomes were analysed in accordance with the ICF-CY. RESULTS: One randomized controlled trial and 18 observational studies were identified. The randomized controlled trial was scored OCEBM level 1, whereas the other studies were scored level 4. The MINORS scores ranged from 2 to 18. CONCLUSION: There is preliminary evidence for beneficial effects of serial casting and surgery on passive ankle dorsiflexion as well as on walking kinetics and kinematics, although normalization does not seem to occur. Botulinum toxin type A does not improve the results of casting. Only after surgery are sustainable effects lasting > 1 year reported. Effectiveness on functional activities and social participation has yet to be demonstrated.Downloads
Downloads
Published
How to Cite
Issue
Section
License
All digitalized JRM contents is available freely online. The Foundation for Rehabilitation Medicine owns the copyright for all material published until volume 40 (2008), as from volume 41 (2009) authors retain copyright to their work and as from volume 49 (2017) the journal has been published Open Access, under CC-BY-NC licences (unless otherwise specified). The CC-BY-NC licenses allow third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
From 2024, articles are published under the CC-BY licence. This license permits sharing, adapting, and using the material for any purpose, including commercial use, with the condition of providing full attribution to the original publication.
